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Abstract
Background: Although there is considerable evidence for a loss of bone mass with weight loss,
the few human studies on the relationship between weight cycling and bone mass or density have
differing results. Further, very few studies assessed the role of dietary composition on bone mass
during weight cycling. The primary objective of this study was to determine if a diet high in amylase-
resistant starch (RS2), which has been shown to increase absorption and balance of dietary
minerals, can prevent or reduce loss of bone mass during weight cycling.
Methods: Female Sprague-Dawley (SD) rats (n = 84, age = 20 weeks) were randomly assigned to
one of 6 treatment groups with 14 rats per group using a 2 × 3 experimental design with 2 diets
and 3 weight cycling protocols. Rats were fed calcium-deficient diets without RS2 (controls) or diets
high in RS2 (18% by weight) throughout the 21-week study. The weight cycling protocols were
weight maintenance/gain with no weight cycling, 1 round of weight cycling, or 2 rounds of weight
cycling. After the rats were euthanized bone mineral density (BMD) and bone mineral content
(BMC) of femur were measured by dual energy X-ray absorptiometry, and concentrations of
calcium, copper, iron, magnesium, manganese, and zinc in femur and lumbar vertebrae were
determined by atomic absorption spectrophotometry.
Results: Rats undergoing weight cycling had lower femur BMC (p < 0.05) and marginally lower
BMD (p = 0.09) than rats not undergoing weight cycling. In comparison to controls, rats fed RS2
had higher femur BMD (p < 0.01) and BMC (p < 0.05), as well as higher values for BMD and BMC
measured at the distal end (p < 0.001 and p < 0.01) and femoral neck (p < 0.01 and p < 0.05).
Consistent with these findings, RS2-fed rats also had higher femur calcium (p < 0.05) and magnesium
(p < 0.0001) concentrations. They also had higher lumbar vertebrae calcium (p < 0.05) and
magnesium (p < 0.05) concentrations.
Conclusion: Weight cycling reduces bone mass. A diet high in RS2 can minimize loss of bone mass
during weight cycling and may increase bone mass in the absence of weight cycling.
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Background
Although obesity has a number of well-documented
adverse effects on health, obese men and women have
higher bone mineral density (BMD) and bone mineral
content (BMC) than their age and gender-matched coun-
terparts with lower body weights [1]. Weight cycling is the
repeated loss and regain of body weight, and occurs fre-
quently in obese and overweight men and women in their
attempts to lose weight and maintain a lower body
weight. Weight cycling may also occur in men and women
of normal body weight or in those with eating disorders
such as anorexia nervosa. The goal of intentional weight
loss is to reduce fat mass, but there is typically an accom-
panying unwanted loss of lean body mass, including bone
mass [1]. Although there is convincing evidence for a loss
of bone mass with weight loss [1], there are only a few
human studies on the relationship between weight cycling
and bone mass or density. A small number of epidemio-
logic studies demonstrate that a history of weight cycling
is associated with a reduction in bone mineral density or
an increased risk of hip and other fractures in men and
women [2-5]. In one of these studies [2], greater weight
variability in a sample of about 20,000 women and
19,000 men was associated with relative risks of hip frac-
ture of 2.07 for women and 2.70 for men. In another
study of 169 premenopausal women [3], weight cycling
was associated with significant (p < 0.01) decreases in
BMD at the lumbar spine and distal radius. In the above
studies, the significant relationships between weight
cycling and hip fracture or BMD persisted even after cor-
rection for body weight. In more recent studies, Sogaard et
al. [4] found that weight cycling in elderly Norwegian
men was a risk factor for forearm fracture, and Bacon et al.
[5] reported that chronic dieting in 30–45 year old obese
women was associated with low bone mass. In contrast
other investigators found that weight cycling did not
reduce bone mass in competitive athletes [6] and over-
weight, sedentary, premenopausal women [7]. The vary-
ing results of the above and other human studies on the
relationship between weight cycling and bone mass may
be due to the many factors that cannot be adequately con-
trolled in human studies, including subject diets, compli-
ance with the study protocol, and patterns of weight loss.
Furthermore, a history of weight cycling may define a sub-
group of people at risk for bone loss due to other factors.
It is not known if dietary composition during weight
cycling can influence bone mass, quality, and strength;
specific diet components that may influence bone during
weight cycling include vitamins D and K, calcium, magne-
sium, several essential trace minerals, and the resistant
starches. Resistant starches (RS1, RS2, RS3, RS4 and RS5) are
subgroups of fiber that occur naturally in foods or can be
produced during food processing [8-11]. Total resistant
starch is estimated to be about 10% (range = 2–20%) of
ingested starches in Western diets [8]. The resistant
starches are not digested by mammalian enzymes in the
mouth, stomach, or small intestine, but may be fermented
in the colon [8-11]. Categorization of the five types of
resistant starch is based on the factors that explain their
resistance to degradation in the upper gastrointestinal
tract. These factors include physical entrapment of the
starch by the native cellular structure (RS1), the physical
structure of the starch granules (RS2), or their chemical
composition (RS3, RS4, and RS5) (8–10). RS2 is the sub-
type most widely used commercially. We selected it for
this investigation because a number of prior studies from
other laboratories provide considerable evidence demon-
strating that dietary RS2 improves absorption and balance
of calcium, magnesium, and several trace minerals in
experimental animals, particularly the rat [12-19]. This
study is based on the hypothesis that RS2, by reducing gas-
trointestinal loss of calcium, magnesium, and other bone
minerals, may help to maintain bone mass subsequent to
weight cycling.
Because of the difficulty of controlling the various factors
that could influence the effects of weight cycling on bone
mass in humans, we conducted a study in rats so that diet
composition, weight cycling patterns, age, and other rele-
vant variables could be tightly controlled. The primary
objective of this investigation was to determine if a diet
high in natural RS2 from high-amylose cornstarch (also
termed "maize starch") can reduce or prevent loss of
femur BMD and BMC subsequent to weight cycling in
female rats. The female Sprague-Dawley (SD) rat was cho-
sen as the experimental model based on prior studies in
our laboratories in this species; these studies suggest that
the female SD rat is an appropriate model for the study of
relationships between weight loss and bone composition
[20-24]. A second goal was to analyze bone for other min-
erals and trace elements that are known or suspected to be
required for optimal bone strength, specifically calcium,
copper, iron, magnesium, manganese, and zinc [25]. This
was done to obtain insight into specific bone metals that
may be involved in the effects of weight cycling and/or
dietary resistant starch on bone. A third goal was to ana-
lyze selected non-calcified organs (liver and kidney) with
high metabolic activity for the same metals in order to
compare effects of weight cycling and dietary resistant
starch on bone versus soft tissue minerals.
Methods
Diet preparation
Diets were formulated and prepared by Research Diets,
Inc., New Brunswick, NJ. The composition of these diets is
described in Table 1. Carbohydrate in each diet is pro-
vided by waxy cornstarch, pregelatinized waxy cornstarch,
and sucrose. A mixture of waxy cornstarch, pregelatinized
waxy cornstarch, and sucrose was used for the controlNutrition & Metabolism 2008, 5:34 http://www.nutritionandmetabolism.com/content/5/1/34
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(normal) diets to provide a resistant-starch-free formula-
tion capable of being formed into pellets. For the diets
containing resistant starch, Hi-maize 260®  starch
(National Starch and Chemical Company, Bridgewater,
NJ) was substituted for a portion of the waxy cornstarch
(Amioca, 0% amylose). Hi-maize 260 starch, a hydrother-
mally-treated RS2 starch composed of 60% total dietary
fiber as RS2-type granules, is derived from cornstarch high
in amylose but is resistant to enzymatic degradation by
amylase. A target of 18–20% by weight of Hi-maize 260
starch was chosen because diets with a similar concentra-
tion of this component have been shown to improve
retention of calcium, magnesium, and some trace miner-
als in the rat [17].
The study was designed to ensure comparable dietary
intake in all treatment groups during weight gain or
weight loss of calcium, phosphorus, magnesium, and
each of the essential vitamins and trace minerals. To
achieve this goal, 4 diet formulations were required, as
described in Table 1. The diets were formed into cylindri-
cal pellets (22 mm × 12 mm in diameter) and colored
with FD&C dyes to provide a distinct color for each diet
formulation and facilitate conduct of the study by allow-
ing easy identification of each of the four diets. Diet
NDWL (normal diet for weight loss) was formulated to
have concentrations of AIN-76 salt mix, calcium phos-
phate, AIN-76A vitamin mix, and choline bitartrate that
were 40% higher than Diet ND (normal ad lib diet). Sim-
ilarly, Diet RSWL (resistant starch (RS2) weight loss diet)
was formulated to have concentrations of AIN-76 salt mix,
calcium phosphate, AIN-76A vitamin mix, and choline
bitartrate that were 40% higher than Diet RS (resistant
starch (RS2) ad lib diet). Diets ND and RS were fed except
Table 1: Composition of calcium-deficient normal and resistant starch pelleted diets fed during weight maintenance/gain and during 
40% energy restriction
Ad Lib 40% kcal Restricted
ND RS NDWL RSWL
Macronutrients % gm % kcal% gm % kcal % gm % kcal % gm % kcal
Protein 19.5 21 18.4 21 19.2 21 18.2 21
Carbohydrate 67.3 64 69.1 64 66.3 64 68.1 64
Fat 6.2 15 5.9 15 6.2 15 5.8 15
Total 93.0 100 93.4 100 91.7 100 92.1 100
Energy/gram 3.74 kcal/g 3.54 kcal/g 3.69 kcal/g 3.49 kcal/g
Ingredients gm kcal gm kcal gm kcal gm kcal
Casein, 80 Mesh 200 800 200 800 200 800 200 800
DL-Methionine 3 12 3 12 3 12 3 12
Waxy Cornstarch, 500.5 1752 361.5 1265 492.5 1724 354 1239
Pregelatinized Waxy Cornstarch 100 350 100 350 100 350 100 350
Sucrose 91 364 91 364 91 364 91 364
High Amylose Cornstarch 0 0 200 486 0 0 200 486
Cellulose, BW200 50 0 50 0 50 0 50 0
Corn Oil 65 585 65 585 65 585 65 585
AIN-76 Salt Mix, S10001A w/o Ca and P 17.5 0 17.5 0 29.2 0 29.2 0
Dibasic Calcium Phosphate, 29.5% Ca, 22.8% P 3.4 0 3.4 0 5.65 0 5.65 0
AIN-76A Vitamin Mix, V10001 10 40 10 40 16.7 67 16.7 67
C h o l i n e  B i t a r t r a t e 2 0 20 3 . 30 3 . 30
FD&C Yellow Dye #5 0.05 0 0 0 0 0 0.025 0
FD&C Red Dye #40 0 0 0.05 0 0 0 0 0
FD&C Blue Dye #1 0 0 0 0 0.05 0 0.025 0
Totals 1042.45 3903 1103.45 3902 1056.4 3902 1117.9 3903
Waxy Cornstarch and Pregelatinized Waxy Cornstarch–3.5 kcal/g, High Amylose Cornstarch –2.43 kcal/g
ND = normal (control) diet fed ad lib during periods of weight maintenance or weight gain
RS = resistant starch diet fed ad lib during periods of weight maintenance or weight gain
NDWL = normal (control) diet fed during energy restriction/weight loss
RSWL = resistant starch diet fed during energy restriction/weight lossNutrition & Metabolism 2008, 5:34 http://www.nutritionandmetabolism.com/content/5/1/34
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when rats were undergoing energy restriction to achieve
weight loss; during energy restriction diets NDWL or
RSWL were fed.
The target calcium concentration for Diets ND and RS was
1.0 mg of calcium per gram of diet (0.1% calcium by
weight = 25 μmol/g), a concentration that is 20% of the
calcium concentration of the standard AIN-76 diet, and
can be considered to be moderately deficient for the rat.
This approach was used because many younger adults and
more than 50% of older adults living in the United States,
including those who use calcium-containing antacids or
supplements, consume diets that are considered to be
inadequate in calcium [26], and thus may be at higher risk
of loss of bone mass during weight loss [27].
Animal care and treatment
Female rats were chosen for this study because low BMD
and BMC, as well as a higher risk of osteoporosis and oste-
oporosis-related fractures, are more common in women
than men, and because of our prior experience studying
effects of weight loss on bone in women and female rats
[20-24].
The number of rats chosen per treatment group (n = 14)
exceeds the number per group (as few as 6) in prior stud-
ies conducted in our laboratories [20-23] that demon-
strate significant loss of bone mass after weight loss. In
addition we conducted a power analysis based on the
effect of a projected 18% loss of body weight on bone
density in the rat. Using conservative assumptions and
data from our prior studies, the power analysis showed
that with 12 rats per treatment group and alpha = 0.05,
there is 90% power to detect a difference in BMD between
treatment groups of 4.7% and 80% power to detect a dif-
ference of 4.0%. Thus, it was anticipated that 14 rats per
group would provide adequate statistical power to detect
treatment effects of moderate size on the major outcome
variables of BMD and BMC even with attrition of as many
as 2 rats per group.
Sexually mature female Sprague-Dawley (SD) rats
(Charles River, Raleigh, NC, n = 84, age = 20 weeks) were
randomly assigned to one of six treatment groups with 14
rats per group using a 2 × 3 experimental design with 2
diets and 3 weight cycling protocols. Because body weight
is strongly associated with bone mass, rats were stratified
by body weight prior to random assignment to one of the
6 treatment groups to ensure nearly identical initial mean
body weights in each of the 6 groups. As anticipated, this
approach to random assignment resulted in very similar
mean body weights at randomization (281.2–282.5 g) in
each of the six treatment groups (Figure 1). Rats were fed
pelleted diets without RS2 (ND = normal diets, controls)
or diets high in RS2 (17.9–18.1%) throughout the study.
The weight cycling protocols were: weight maintenance
with no weight cycling (Groups ND0 and RSD0), 1 round
of weight cycling (Groups ND1 and RSD1), or 2 rounds of
weight cycling (Groups ND2 and RSD2).
Diets ND or RS were fed upon arrival of the rats in our lab-
oratories for 8 days prior to the initiation of energy restric-
tion/weight loss. The plan and chronology of weight loss
and weight regain is illustrated in Figure 1. The timing of
the single round of weight cycling for those rats undergo-
ing this treatment coincided with the final (second) round
of weight cycling in rats undergoing 2 rounds of weight
cycling. Weight loss was achieved by restriction of energy
intake to 60% of that of rats in groups fed ad lib, as in our
prior studies [20,21,23]. All rats were allowed to consume
feed ad lib when not undergoing weight loss.
Feed consumption was monitored by weighing all feed
provided and subtracting feed not eaten. Feed consumed
by rats eating ad lib during a week was used to calculate the
reduced amounts of feed provided to rats consuming
energy restricted diets during the following week. When
rats were consuming diets ad lib, they were fed once per
week. When rats were consuming energy restricted diets,
they were fed daily including weekends, and invariably ate
all feed provided.
Rats were housed throughout the study in individual
cages in a separate, locked room in the New Jersey Medical
School Research Animal Facility, which is AAALAC accred-
ited. Cages and cage racks were labeled with tape of six dif-
ferent colors to facilitate identification of rats in each of
the six treatment groups. No other animals were housed
in the room during the study. Blood withdrawal was done
in a nearby procedure room within the Research Animal
Facility
After completion of the second round of weight regain
after 21 weeks, blood was obtained by cardiac puncture
under anesthesia with 0.6 ml/100 g of a mixture of keta-
mine (20 mg/ml) and xylazine (2.5 mg/ml) administered
intraperitoneally. Rats were then euthanized by decapita-
tion after administration of additional anesthetic if neces-
sary. Both femurs and the spinal column bones of the
lumbar region were harvested. Other organs harvested
from each rat were liver and kidney. Procedures used to
harvest the organs have been used on many occasions in
our laboratory and have been designed to minimize the
potential of organ metal contamination during harvest-
ing. For the right femur to be used for measurement of
BMD and BMC, femurs were preserved by wetting them
with 50% physiological saline (0.42%) solution and
wrapping them in cotton gauze saturated with 50% saline
prior to freezing. All blood and organ samples were stored
at -70°C until analysis.Nutrition & Metabolism 2008, 5:34 http://www.nutritionandmetabolism.com/content/5/1/34
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Laboratory analyses
After placing the excised femur on a Delrin block, BMC
and BMD of the right femurs were determined by dual
energy x-ray absorptiometry (DEXA) using a GE-Lunar
PIXImus densitometer with software version 1.4×. The
PIXImus densitometer uses a 14 degree stationary anode
X-ray tube generator with a 0.25 mm × 0.25 mm focal spot
that generates a cone beam X-ray (55/80 kVp at 400 μA).
The right femurs were analyzed for the whole bone "total"
BMD and BMC, and at 2 other standard sites prone to frac-
ture, specifically the femoral neck and the distal femur
(20% from the distal end of the bone) [28].
After non-destructive analysis by DEXA, the right femurs
were subsequently used for laboratory analyses of their
mineral composition; this enabled measurement of min-
Rat body weights Figure 1
Rat body weights. Mean body weights of rats in the six treatment groups during the 21-week duration of the study. N = 84 
rats. Each point in the figure is the mean for the 14 rats in each of the 6 treatment groups.Nutrition & Metabolism 2008, 5:34 http://www.nutritionandmetabolism.com/content/5/1/34
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eral concentrations using the same bone that was used to
determine BMD and BMC. The right femur and lumbar
vertebrae bones were analyzed for minerals and trace ele-
ments that are considered to be essential or beneficial for
optimal bone strength, specifically calcium, copper, mag-
nesium, manganese, and zinc [25]. Iron was also deter-
mined in these samples. For these analyses the entire right
femur and a set of 3–4 lower lumbar vertebrae were
assayed; the bone samples were cleaned of all non-calci-
fied tissue before analysis. The non-calcified organs col-
lected (kidney and liver) were also analyzed for the same
metals. These analyses were conducted using flame or
electrothermal atomic absorption spectrophotometry.
Standards, blanks, and National Institute of Standards
and Technology (NIST, Gaithersburg, MD) Standard Ref-
erence Materials (SRM # 1486–Bone Meal or SRM #
1577b–Bovine Liver) with certified values for their metal
concentrations were analyzed with each set of daily anal-
yses as a component of our quality control program
[20,21].
Data analysis
Data evaluation methods included descriptive and infer-
ential statistical analyses. Two-way ANOVA was con-
ducted to determine the separate effects of dietary
resistant starch and weight cycling, as well as their interac-
tions, on the various study outcome variables. Pairwise
differences were evaluated subsequent to 2-way ANOVA
by comparison of least-square means at p < 0.05. Associa-
tions between selected variables were determined by cal-
culation of Pearson correlation coefficients. A limited
number of multiple regression analyses were conducted
with BMD or BMC as the dependent variable and final
body weight and treatment group as the independent var-
iables.
Ethical treatment of animals
All applicable institutional and governmental regulations
concerning the ethical use of animals were followed dur-
ing this research. The study and its specific procedures
were reviewed and approved by the UMDNJ-New Jersey
Medical School Institutional Animal Care and Use Com-
mittee.
Results
Food consumption
Rats fed the normal diets and their counterparts fed the
resistant starch diets had similar total food intakes (mean
± SE) during the 21-week study, specifically 2566 ± 97 g
and 2585 ± 88 g for those rats not undergoing weight
cycling, 2333 ± 59 g and 2424 ± 53 g for those rats subject
to one round of weight cycling, and 2142 ± 31 g and 2118
± 55 g for those rats undergoing two rounds of weight
cycling.
Diet composition
Table 2 contains the results of our analyses of diet concen-
trations of iron and the 5 metals for which there is evi-
dence that they are essential (Ca) or likely to be important
(Cu, Mg, Mn, Zn) in the maintenance of bone mineral
density and bone mineral content. Our target for diets
moderately deficient in calcium for the rat was a concen-
tration of 1.0 mg of calcium per gram of diet (25.0 μmol/
g). Measured mean calcium concentrations for Diets ND
and RS fed during periods of weight maintenance or
weight gain were 1.09 mg/g (27.2 μmol/g) and 1.07 mg/g
(26.7 μmol/g), and thus are within 10% of the target con-
centration. Calcium present in other food components
besides the dibasic calcium phosphate used to add cal-
cium to the diets likely contributed to the total calcium
concentration of the diets. Diets NDWL and RSWL that
Table 2: Essential mineral concentrations of custom calcium-deficient diets
Diet Calcium μmol/g Copper μmol/g Iron μmol/g Magnesium μmol/g Manganese μmol/g Zinc μmol/g
ND 27.20 ± 0.44 0.094 ± 0.004 0.775 ± 0.018 21.39 ± 0.13 0.978 ± 0.020 0.577 ± 0.006
RS 26.70 ± 0.53 0.092 ± 0.001 0.736 ± 0.022 20.56 ± 0.21 0.923 ± 0.011 0.539 ± 0.007
NDWL 41.17 ± 0.88 0.136 ± 0.004 1.074 ± 0.007 34.14 ± 0.40 1.429 ± 0.010 0.809 ± 0.008
RSWL 37.92 ± 0.76 0.134 ± 0.002 1.043 ± 0.021 32.49 ± 0.18 1.372 ± 0.027 0.780 ± 0.008
AIN 76 129.7 0.094 0.63 20.6 1.07 0.55
Ratio:
NDWL/ND 1.51 1.44 1.39 1.60 1.46 1.40
RSWL/RS 1.42 1.45 1.42 1.58 1.49 1.45
ND = normal diet fed ad lib during periods of weight maintenance or weight gain
RS = resistant starch diet fed ad lib during periods of weight maintenance or weight gain
NDWL = normal diet fed during periods of weight loss
RSWL = resistant starch diet fed during periods of weight loss
AIN 76 = concentrations in the standard American Institute of Nutrition 1976 Rodent Diet 
Concentrations are mean ± SE N = 8 for all valuesNutrition & Metabolism 2008, 5:34 http://www.nutritionandmetabolism.com/content/5/1/34
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were fed during periods of weight loss at 60% of ad lib
were intended to have calcium concentrations that were
40% (1.40-fold) greater than Diets ND and RS; measured
values were 51% and 42% greater, respectively. The latter
results are based on 8 replicate analyses, but even well
mixed solid diets may have some degree of heterogeneity.
Measured concentrations of Cu, Fe, Mg, Mn, and Zn in
Diets ND and RS were near the target levels for the AIN-76
diet for rodents that are provided in Table 2.
Body weights
Figure 1 depicts mean body weights for the 14 rats in each
of the six treatment groups. These data demonstrate that
we were able to successfully produce weight loss and
regain in the groups of rats undergoing one round of
weight cycling (ND1 and RSD1) or two rounds of weight
cycling (ND2 and RSD2). The results further demonstrate
that body weights in the normal diet and corresponding
resistant starch diet groups (ND0 versus RSD0 and ND2
versus RSD2) tracked closely with one another through-
out the study. Final body weights differed slightly between
the ND0 and RSD0 groups (7.3 g = 1.7% difference in
mean final body weights), and the ND2 and RSD2 groups
(8.6 g = 2.5% difference in mean final body weights).
Final body weights differed more substantially between
the ND1 and RSD1 groups (20.1 g = 5.1% difference in
mean final body weights). Despite random assignment of
rats to the six treatment groups and virtually identical
mean group body weights subsequent to random assign-
ment to groups (see Figure 1, Day 0), the body weights of
the latter two groups did not track as closely as the other
groups described above (see Figure 1).
Bone mineral density & content
Figure 2 contains the results for BMD and BMC for right
femurs of the rats. Results are provided for the BMD and
BMC of the entire femur, as well as for the distal femur
and femoral neck, for a total of six variables. Pairwise
comparisons in Figure 2 reveal that the values for BMD
and BMC were always higher (total of 18 pairwise com-
parisons) in rats fed the diets containing resistant starch
than in the corresponding rats fed the normal diets with-
out added resistant starch (ND0 versus RSD0, ND1 versus
RSD1, ND2 versus RSD2). Mean values for BMD-total in
the RSD0, RSD1, and RSD2 groups were 3.4%, 2.0%, and
8.2% higher, respectively, than those of corresponding
rats in the ND0, ND1, and ND2 groups. Values were sim-
ilarly higher for BMD-femoral neck (7.1%, 6.8%, and
18.2%) and BMD-distal femur (7.2%, 6.4%, and 9.0%) in
the RSD groups than the corresponding ND groups. The
same pattern was observed for percentage differences in
BMC between the RSD versus ND groups. The above
results show that BMD and BMC were consistently higher
in rats fed the resistant starch diets than in their counter-
parts fed the control diets; this result cannot be explained
by differences in body weights between rats fed the resist-
ant starch diets and their counterparts fed the normal
diets because their body weights were very similar
throughout the study (Figure 1).
Pearson correlation coefficients for the associations
between BMD-total, BMD-femoral neck, and BMD-distal
femur and the corresponding values for BMC were 0.818,
0.974, and 0.875 (n = 83–84, p < 0.0001).
We evaluated the results for BMD and BMC using 2-way
ANOVA (Table 3) to determine the independent effects of
diet (RS2 versus ND diet) and weight cycling protocol (0,
1, or 2 rounds of weight cycling), as well as the effect of
diet/weight cycling interactions, on these variables. Com-
pared to rats fed the normal diet, rats fed the RS2 diet had
significantly higher BMD-total, BMD-distal femur, and
BMD-femoral neck; the corresponding values for BMC
were also significantly higher in RS2 -fed rats. Rats under-
going weight cycling had significantly lower BMC-total
than rats not undergoing weight cycling. Weight cycling
did not significantly affect the other 5 measures of BMD
and BMC, although the effect of weight cycling on BMD-
total approached statistical significance (p = 0.09). Weight
cycling and diet did not interact to significantly influence
any measure of BMD or BMC.
Figure 1 shows that rats in the four treatment groups
undergoing weight cycling (ND1, ND2, RSD1, RSD2) had
mean body weights that at their minimum values were
about 80–120 g lower than those of rats not undergoing
weight cycling (groups ND0 and RSD0). Rats undergoing
weight cycling also had substantially lower final body
weights. As expected, final body weights were significantly
associated with BMD-total (r = 0.32, p = 0.003) and with
BMC-total (r = 0.46, p < 0.0001). Therefore, to further
define relationships among BMD, final body weight, and
treatment group, we conducted a multiple regression
analysis. In this model BMD-total was the dependent var-
iable and final body weight and treatment group were the
independent variables. Final body weight and treatment
group were significant (p < 0.01) predictors of BMD-total,
accounting for 18.7% of the variability in BMD-total
(final body weight = 10.3% of variability, treatment group
= 8.3% of variability).
Mineral concentrations
None of the kidney metal concentrations measured dif-
fered significantly among treatment groups. For liver there
were some differences in concentrations among treatment
groups, but no consistent relationships to weight cycling
or diet composition were observed.
Table 4 contains mineral concentrations for femur and
lumbar vertebrae bone samples. We evaluated theseNutrition & Metabolism 2008, 5:34 http://www.nutritionandmetabolism.com/content/5/1/34
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Bone mineral density and bone mineral content Figure 2
Bone mineral density and bone mineral content. Bone mineral density (BMD) and bone mineral content (BMC) of the 
total femur, femoral neck, and distal femur for right femurs of rats in the six treatment groups after 21 weeks. N = 84 rats. 
Each bar in the figure is the mean with standard error for 14 femurs. Mean BMD and BMC are consistently higher for rats fed 
the diets containing resistant starch (solid bars) than for their counterparts (adjacent striped bars) fed the normal diets. Values 
not marked with the same upper-case letters (A, B, or C) differ significantly (p < 0.05) by comparison of least-square means. 
Inferential statistical analyses of these data by 2-way ANOVA are provided in Table 3.Nutrition & Metabolism 2008, 5:34 http://www.nutritionandmetabolism.com/content/5/1/34
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results for femur mineral concentrations using 2-way
ANOVA (Table 5) to determine the independent effects of
diet (RS2 versus ND diet) and weight cycling protocol (0,
1, or 2 rounds of weight cycling), as well as diet/weight
cycling interactions, on these variables. Compared to con-
trols fed the normal diet, rats fed the RS2 diet had signifi-
cantly higher femur calcium and magnesium
concentrations, but did not have higher femur concentra-
tions of copper, iron, manganese, and zinc. Weight
cycling had no significant effect on femur metal concen-
trations of calcium, copper, manganese, and magnesium.
However, rats undergoing weight cycling had significantly
lower femur zinc, and there were significant interactions
between weight cycling and diet that influenced femur
iron and zinc concentrations.
Compared to controls fed the normal diet, data evalua-
tion using 2-way ANOVA demonstrated that rats fed the
Table 3: Bone mineral density and content of total femur, femoral neck and distal femur: P values for 2-way ANOVA
Diet Effect Weight Cycling Effect Diet/Weight Cycling Interaction
BMD Total Femur p < 0.01 NSa NS
BMD Femoral Neck p < 0.01 NS NS
BMD Distal Femur p < 0.001 NS NS
BMC Total Femur p < 0.05 p < 0.05 NS
BMC Femoral Neck p < 0.05 NS NS
BMC Distal Femur p < 0.01 NS NS
NS = ≥0.05
Results are for the right femur
ap = 0.09
Diet Effect = normal diets versus resistant starch diets
Weight Cycling Effect = 0, 1, or 2 rounds of weight cycling
Table 4: Calcified tissue mineral concentrations
RIGHT FEMUR
Group Calcium mmol/g Copper nmol/g Iron μmol/g Magnesium mmol/g Manganese nmol/g Zinc μmol/g
ND0 3.98 ± 0.16 9.33 ± 0.55 0.98 ± 0.08 0.118 ± 0.002 11.23 ± 0.57 3.25 ± 0.08
ND1 4.17 ± 0.10 9.44 ± 0.39 1.23 ± 0.10 0.119 ± 0.002 11.30 ± 0.65 2.94 ± 0.07
ND2 4.06 ± 0.07 8.42 ± 0.37 1.15 ± 0.09 0.120 ± 0.002 11.18 ± 0.55 2.81 ± 0.05
RSD0 4.22 ± 0.06 8.83 ± 0.37 1.52 ± 0.15 0.126 ± 0.002 11.61 ± 0.67 2.98 ± 0.07
RSD1 4.26 ± 0.07 8.64 ± 0.36 1.11 ± 0.09 0.127 ± 0.002 10.92 ± 0.79 3.05 ± 0.05
RSD2 4.30 ± 0.09 8.62 ± 0.38 1.10 ± 0.07 0.127 ± 0.002 10.45 ± 0.71 2.96 ± 0.05
LUMBAR VERTEBRAE
Group Calcium mmol/g Copper nmol/g Iron μmol/g Magnesium mmol/g Manganese nmol/g Zinc μmol/g
ND0 4.25 ± 0.12 10.22 ± 0.53 1.19 ± 0.10 0.126 ± 0.002 8.14 ± 0.28 3.25 ± 0.07
ND1 4.26 ± 0.09 10.36 ± 0.69 1.43 ± 0.10 0.123 ± 0.003 8.68 ± 0.45 3.17 ± 0.09
ND2 4.31 ± 0.07 10.84 ± 0.88 1.25 ± 0.06 0.128 ± 0.003 8.11 ± 0.27 3.20 ± 0.06
RSD0 4.48 ± 0.06 10.26 ± 0.49 1.63 ± 0.21 0.132 ± 0.003 8.53 ± 0.33 3.30 ± 0.06
RSD1 4.60 ± 0.23 11.50 ± 0.83 1.22 ± 0.04 0.130 ± 0.003 8.34 ± 0.35 3.27 ± 0.06
RSD2 4.44 ± 0.08 9.84 ± 0.55 1.16 ± 0.07 0.131 ± 0.002 7.70 ± 0.31 3.21 ± 0.09
Values are Mean ± SE based on wet organ weight, n = 14 for all tabular values except that n = 8 for femur copper.
Inferential statistical analyses of these data by 2-way ANOVA are provided in Table 5 for the right femur and Table 6 for the lumbar vertebrae.
ND0 = normal diet with no weight cycling
ND1 = normal diet with 1 round of weight cycling
ND2 = normal diet with 2 rounds of weight cycling
RSD0 = resistant starch diet with no weight cycling
RSD1 = resistant starch diet with 1 round of weight cycling
RSD2 = resistant starch diet with 2 rounds of weight cyclingNutrition & Metabolism 2008, 5:34 http://www.nutritionandmetabolism.com/content/5/1/34
Page 10 of 12
(page number not for citation purposes)
RS2 diet had significantly higher lumbar vertebrae calcium
and magnesium concentrations, but did not have higher
concentrations of copper, iron, manganese, and zinc
(Table 6); these results are consistent with the results for
the femur metal concentrations. Weight cycling did not
significantly affect any of the 6 lumbar vertebrae metal
concentrations measured; however, as observed for the
femur, there was a significant interaction between weight
cycling and diet that influenced lumbar vertebrae iron
concentrations.
Femur calcium, magnesium, and zinc concentrations were
significantly associated with BMD-total (r = 0.24, 0.29,
and 0.23, p < 0.05), but femur copper, iron, and manga-
nese were not (r = 0.04, 0.00, and 0.01, p > 0.05). Simi-
larly, femur calcium, magnesium, and zinc concentrations
were significantly associated with BMC-total (r = 0.28,
0.30, and 0.25, p < 0.05), but femur copper, iron, and
manganese were not (r = 0.02, 0.00, and 0.01, p > 0.05).
Using the femur calcium concentrations and femur
weights, we calculated the total calcium content of the
right femurs. These values were significantly associated
with BMC-total of the right femur (r = 0.943, p < 0.0001),
demonstrating very good agreement between the DEXA
measurements of BMC-total done in the laboratory of one
of the co-authors (SAS) and femur calcium concentrations
measured by flame atomic absorption spectrophotometry
in the laboratory of another co-author (JDB).
Discussion
The results provide the first evidence that a dietary compo-
nent, in this case RS2, can prevent or reduce loss of BMD
and BMC due to weight cycling. Rats fed RS2 also had
higher bone mass in the absence of weight cycling.
Although the differences we found among treatment
groups in BMD and BMC are small-to-moderate in mag-
nitude (2.8–18.2%), they are within the range of the
decreases in BMD and BMC of about 10% that are associ-
ated in women with a substantially increased risk of frac-
tures of the hip, wrist, or spinal column [29,30].
Although BMD and BMC for the total femur, distal femur,
and femoral neck were consistently lower in rats undergo-
ing weight cycling in comparison to those animals not los-
ing weight, the differences were significant (p < 0.05) only
for BMC total. Because we measured BMD and BMC only
after regain of body weight, larger reductions in BMD and
BMC with weight loss may have been partially restored by
the rapid regain of body weight prior to harvesting the
femurs for determination of BMD and BMC.
In the current study rats fed the RS2 diet had significantly
higher femur calcium and magnesium concentrations. We
also found significant pairwise associations between
Table 5: Femur mineral concentrations: P values for 2-way ANOVA
Metal Diet Effect Weight Cycling Effect Diet/Weight Cycling Interaction
Ca p < 0.05 NS NS
Cu NS NS NS
Fe NS NS p < 0.01
Mg p < 0.0001 NS NS
Mn NS NS NS
Zn NS p < 0.01 p < 0.01
NS = p ≥ 0.05
Results are for the right femur
Diet Effect = normal diets versus resistant starch diets
Weight Cycling Effect = 0, 1, or 2 rounds of weight cycling
Table 6: Lumbar vertebrae mineral concentrations: P values for 2-way ANOVA
Metal Diet Effect Weight Cycling Effect Diet/Weight Cycling Interaction
Ca p < 0.05 NS NS
Cu NS NS NS
Fe NS NS p < 0.05
Mg p < 0.05 NS NS
Mn NS NS NS
Zn NS NS NS
NS = p ≥ 0.05
Diet Effect = normal diets versus resistant starch diets
Weight Cycling Effect = 0, 1, or 2 rounds of weight cyclingNutrition & Metabolism 2008, 5:34 http://www.nutritionandmetabolism.com/content/5/1/34
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femur BMD or BMC and femur calcium and magnesium
concentrations. These data suggest that dietary RS2 may
prevent loss of bone mass during weight cycling by
enhancing absorption and retention of calcium and/or
magnesium (as suggested by the Table 5 data for femur
calcium and magnesium), but not the retention of copper,
iron, manganese, and zinc. This result is consistent with
the results of prior studies [16,20] showing that RS2
increases calcium and magnesium absorption; a potential
mechanism for this effect is hypothesized to be the cecal
wall hypertrophy and cecal acidification that RS2-induced
fermentation produces in the large intestine [19].
Lobo et al. [31] have studied the effect of a diet containing
5% fructooligosaccharides (FOS) on intestinal absorption
of calcium and magnesium, bone mineral density, and
bone strength parameters in growing 4-week old male
rats. Compared to controls, rats fed ad lib with FOS had a
higher apparent absorption of calcium and magnesium,
higher femur and tibia calcium concentrations, and
increased femur peak load and yield load. Thus, our study
and that of Lobo et al. suggest that specific dietary carbo-
hydrates may have important roles in building and main-
taining bone mass and strength during weight cycling or
growth, and that the mechanism for this effect may be
enhanced calcium and magnesium absorption and reten-
tion.
A recent study [32] used NHANES III data to estimate the
mean intake of total resistant starch in the diets of USA
residents age one year or older. The mean intake was 4.9
g/day, with a range of 3–8 g/day. The major sources of
resistant starch were breads (21%), cooked cereals and
pasta (19%), vegetables other than legumes (19%),
bananas/plantains (14%), and legumes (9%). Legumes
contained the most resistant starch per serving, as much as
8 grams. Comparison of the above intakes for an adult to
the RS2 dose administered to the rats in the current study
suggests that higher intakes than those found for the
above USA residents studied may be needed to effect
short-term improvements in BMD and BMC. However, it
is possible that long-term consumption of intakes at the
high end of the range of 3–8 g of total resistant starch daily
may improve BMD and BMC.
In the current study 20-week old female rats were fed diets
that were deficient in calcium but that contained levels of
copper, iron, magnesium, manganese, and zinc that were
near AIN-76 target values. Thus, the diets contained nor-
mal/adequate concentrations of the latter five essential
metals that are considered to be important for bone
health. The effects of RS2 on BMD and BMC might differ
from the results found in the current study if the diets
were adequate in calcium or deficient in copper, iron,
magnesium, manganese, and/or zinc. The results might
also differ if male rats or female rats of a different age were
studied, because age and gender have substantial effects
on BMD and BMC and on bone metabolism.
Conclusion
Weight cycling reduces bone mass. However, a diet high
in RS2 can prevent or reduce loss of bone mass during
weight cycling and may increase bone mass in the absence
of weight cycling. The results provide the first evidence
that a dietary component can help preserve BMD and
BMC during weight cycling. If the above effects of dietary
RS2 are found to apply to humans, then increased dietary
RS2 may help to build and preserve BMD and BMC in men
and women, especially during weight cycling.
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